Clinical trial
Investigating Clinical Heterogeneity in Immune Checkpoint Inhibitor-induced Inflammatory Arthritis
NCT07737535 is registered in ClinicalTrials.gov with Johns Hopkins University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Investigating Clinical Heterogeneity in Immune Checkpoint Inhibitor-induced Inflammatory Arthritis
- Lead sponsor
- Johns Hopkins University
- Phase
- Observational
- Overall status
- Active, not recruiting
- Start date
- July 1, 2026
- Completion date
- July 1, 2031
- Enrollment
- 1,000 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
immune checkpoint inhibitor-induced inflammatory arthritis